Version 1
: Received: 28 February 2023 / Approved: 3 March 2023 / Online: 3 March 2023 (06:30:04 CET)
How to cite:
Maksimova, A. S.; Shelkovnikova, T. A.; Ryumshina, N. I.; Mochula, O. V.; Vaizov, V. K.; Trubacheva, I. A.; Novikova, O. M.; Naiman, A. B.; Kuznetsova, A. D.; Chesalov, N. P.; Ussov, W. Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1
Maksimova, A. S.; Shelkovnikova, T. A.; Ryumshina, N. I.; Mochula, O. V.; Vaizov, V. K.; Trubacheva, I. A.; Novikova, O. M.; Naiman, A. B.; Kuznetsova, A. D.; Chesalov, N. P.; Ussov, W. Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints 2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1
Maksimova, A. S.; Shelkovnikova, T. A.; Ryumshina, N. I.; Mochula, O. V.; Vaizov, V. K.; Trubacheva, I. A.; Novikova, O. M.; Naiman, A. B.; Kuznetsova, A. D.; Chesalov, N. P.; Ussov, W. Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1
APA Style
Maksimova, A. S., Shelkovnikova, T. A., Ryumshina, N. I., Mochula, O. V., Vaizov, V. K., Trubacheva, I. A., Novikova, O. M., Naiman, A. B., Kuznetsova, A. D., Chesalov, N. P., Ussov, W. Y., & Nina D. Anfinogenova, A. (2023). Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints. https://doi.org/10.20944/preprints202303.0059.v1
Chicago/Turabian Style
Maksimova, A. S., Wladimir Yu. Ussov and And Nina D. Anfinogenova. 2023 "Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic" Preprints. https://doi.org/10.20944/preprints202303.0059.v1
Abstract
The aim of study was to investigate epidemiology aspects of magnetic resonance imaging (MRI) during COVID-19 pandemic. The study comprised depersonalized residents of Tomsk and Tomsk Region (n = 1714). Invitations to take online survey were sent to 50,000 residents by target SMS with response rate of 1.2% (n = 727, Cohort 1). Cohort 2 comprised retrospective patients (n = 987) who underwent contrast-enhanced cardiac MRI (CMR) in 2019-2022. Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. 29% of respondents in cohort 1 received MRI examination within past two years; 26% of respondents considered MRI the most informative imaging modality for detecting COVID-19 pneumonia; 12% of respondents reported MRI unavailable. Proportion of CMR among MRI studies increased during COVID-19 pandemic, and maximum incidence of cardiac diseases detected by MRI was in 2021. Incidence of myocardial fibrosis increased from ~67% in 2019 to ~84% in 2022. The rate of outpatient MRI studies significantly increased in 2020, but returned to pre-pandemic level in 2021. COVID-19 pandemic increased the need for MRI and CMR. Patients with history of COVID-19 had persistent and newly occurring symptoms of myocardial damage suggesting chronic cardiac involvement requiring continuous follow-up.
Keywords
COVID-19; long COVID-19; paramagnetic contrast-enhanced cardiac magnetic resonance imaging; MRI; CMR; myocarditis; electronic medical record; online survey; epidemiology; public health
Subject
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.